Evidence map›Paper›PMID 33951050›Full record

ArticlePLoS biology2021

Epidemiology and reporting characteristics of preclinical systematic reviews.

Victoria T Hunniford, Joshua Montroy, Dean A Fergusson, Marc T Avey, Kimberley E Wever, Sarah K McCann, Madison Foster, Grace Fox, Mackenzie Lafreniere, Mira Ghaly and 11 more

Abstract read
In one paragraph

Article in PLoS biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Victoria T HunnifordClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-2288-624X
Joshua MontroyClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Dean A FergussonClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Marc T AveyICF International Incorporated, Ottawa, Canada.ORCID 0000-0002-8696-3232
Kimberley E WeverSYstematic Review Center for Laboratory animal Experimentation (SYRCLE), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0003-3635-3660
Sarah K McCannQUEST Center for Transforming Biomedical Research, Berlin Institute of Health (BIH) and Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-4737-2349
Madison FosterClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0003-2247-8585
Grace FoxClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-4039-4468
Mackenzie LafreniereClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Mira GhalyClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-7961-9919
Sydney MannellClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Karolina GodwinskaClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Avonae GentlesClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-0457-8606
Shehab SelimDepartment of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Jenna MacNeilDepartment of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Lindsey SikoraHealth Sciences Library, University of Ottawa, Ottawa, Canada.ORCID 0000-0002-9715-8634
Emily S SenaCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Matthew J PageSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Malcolm MacleodCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
David MoherCentre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.ORCID 0000-0003-2434-4206
Manoj M LaluClinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-0322-382X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In an effort to better utilize published evidence obtained from animal experiments, systematic reviews of preclinical studies are increasingly more common-along with the methods and tools to appraise them (e.g., SYstematic Review Center for Laboratory animal Experimentation [SYRCLE's] risk of bias tool). We performed a cross-sectional study of a sample of recent preclinical systematic reviews (2015-2018) and examined a range of epidemiological characteristics and used a 46-item checklist to assess reporting details. We identified 442 reviews published across 43 countries in 23 different disease domains that used 26 animal species. Reporting of key details to ensure transparency and reproducibility was inconsistent across reviews and within article sections. Items were most completely reported in the title, introduction, and results sections of the reviews, while least reported in the methods and discussion sections. Less than half of reviews reported that a risk of bias assessment for internal and external validity was undertaken, and none reported methods for evaluating construct validity. Our results demonstrate that a considerable number of preclinical systematic reviews investigating diverse topics have been conducted; however, their quality of reporting is inconsistent. Our study provides the justification and evidence to inform the development of guidelines for conducting and reporting preclinical systematic reviews.

Indexed as

Animal ExperimentationAnimalsBiasChecklistDrug Evaluation, PreclinicalEmpirical ResearchEpidemiologic MethodsEpidemiologyHumansPeer Review, ResearchPublicationsReproducibility of ResultsResearch Design

Identifiers

PMID33951050
PMCPMC8128274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.